GlassScriptPhysician profile
Stacey J Burns
NPI 1427243740
$2,729.18
in general payments reported to CMS, 2019-2025
38 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $376 · 2021: $734 · 2022: $666 · 2023: $225 · 2024: $298 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $397.76 | 2021-2025 | Ubrelvy |
| Novo Nordisk INC | $350.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $304.48 | 2019-2025 | Evenity, Prolia, Prolia |
| Daiichi Sankyo INC. | $214.14 | 2021-2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $205.74 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $118.49 | 2019-2023 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.76 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.17 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $63.74 | 2020-2022 | |
| Amarin Pharma, INC. | $62.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $60.30 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $60.24 | 2021 | |
| Pfizer INC. | $59.42 | 2023-2024 | |
| Irhythm Technologies, INC. | $50.54 | 2024 | Zio Xt Patch, Zio Monitor |
| Allergan, INC. | $49.87 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.